Back to Search
Start Over
826O Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial.
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS773-S774. 2p. - Publication Year :
- 2021
- Subjects :
- *MUCOSA-associated lymphoid tissue lymphoma
*RITUXIMAB
*PLACEBOS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152688468
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.119